David Pyott

David E.
I.
Pyott is Chief Executive Officer & Director at Serica Technologies, Inc. He is Chairman at Bioniz Therapeutics, Inc. since 2016.
He serves as Vice Chairman at Chapman University.
He is Chairman-Governing Board at London Business School since 2015.
He is Director at MAP Pharmaceuticals LLC since 2013.
He is Director at Biotechnology Innovation Organization.
He is Independent Director at Alnylam Pharmaceuticals, Inc. since 2015.
He is Director at Pan-American Ophthalmological Foundation.
He is Director at Cosmetic Surgery Foundation, Inc. He is Independent Director at Tarsus Pharmaceuticals, Inc. starting 2026.
He is Director at Paul Merage School of Business.
He is Independent Director at Pliant Therapeutics, Inc. since 2021.
He is President at Vicept Therapeutics, Inc. He is President at International Council of Ophthalmology Foundation since 2012.
He is President at Ophthalmology Foundation since 2020.
He is Trustee at California Institute of Technology since 2019.
Formerly, he was Chairman & Chief Executive Officer at Allergan, Inc. from 2013 to 2015.
He was President & Chief Executive Officer at Sandoz Nutrition Corp.
from 1992 to 1995.
He was Lead Independent Director at Avery Dennison Corp.
from 2012 to 2020.
He was Independent Director at Edwards Lifesciences Corp.
from 2011 to 2014.
He was Director at Pacific Mutual Holding Co. He was Independent Director at BioMarin Pharmaceutical, Inc. from 2016 to 2025.
He was Director at Pacific LifeCorp.
He was Director at California Healthcare Institute.
He was Director at Rani Therapeutics LLC.
He was Head-Nutrition Division at Novartis AG.
He was Independent Member-Supervisory Board at Koninklijke Philips NV from 2015 to 2025.
Education includes graduation from The University of Edinburgh and an MBA from London Business School in 1980.